Eurofins Completes Strategic Acquisition of Related Party-Owned Sites

On 2 September 2025, Eurofins Scientific announced the completion of its acquisition of related party-owned sites. The transaction encompasses all sites of strategic interest, aligning with previously communicated valuations and scope. This move follows a high 95.6% approval at the company's Annual Ordinary General Meeting on 24 April 2025.

The acquisition aims to reduce annualized rent expenses to negligible levels and ultimately eliminate them as leases on remaining sites conclude. Financing was secured through senior unsecured Euro-denominated bonds issued on 5 August 2025. The acquisition's impact on Eurofins’ financial leverage ratio is estimated to be minimal, at less than 0.2x.

This strategic purchase is a part of Eurofins' ongoing expansion in bioanalytical testing, bolstering its position as a global leader in this domain.